Ghent University Academic Bibliography

Advanced

Medication use and disease management of type 2 diabetes patients in Belgium

Els Mehuys UGent, Leen De Bolle UGent, Lucas Van Bortel UGent, Lieven Annemans UGent, Inge Van Tongelen UGent, Jean Paul Remon UGent and Mimi Giri UGent (2008) PHARMACY WORLD & SCIENCE. 30(1). p.51-56
abstract
Objective The aim of this study was (International Diabetes Federation. Diabetes Atlas Second Edition Executive Summary. Brussels: International Diabetes Federation; 2003) to describe the current status of medication use and disease management of type-2 diabetic patients in Flanders (Belgium). Each patient completed a questionnaire collecting personal data, information on duration of diabetes, medication, diabetes symptoms and self-management. At inclusion, patients measured their fasting plasma glucose (FPG) on three consecutive days. Prescription drugs (antidiabetic and other) purchased by each patient during the 12 months prior to inclusion in the study were reviewed from anonymized computerized pharmacy records. Main outcome measures Degree of self-management, glycaemic control and medication use. Results The mean FPG of the sample was 150.7 +/- 43.0 mg/dl. Controlled glycaemia (FPG between 90 and 130 mg/dl (5.0-7.2 mmol/l)) was achieved in only 34.9% of the patients. Mainstay of hypoglycemic treatment consisted of metformin monotherapy (29.6%) and metformin combined with sulfonylurea (29.0%). Regarding co-medication, 76.9% of the patients used antihypertensive drugs whereas only 33.1% and 39.9% were on aspirin and statin therapy, respectively. ADA recommendations for annual eye and foot examination were not followed in 38.8% (eye) and 39.2% (feet) of the patients. Conclusion The current management of type-2 diabetic Flemish patients falls short of recommended treatment goals. Community pharmacists may play a role in enhancing the awareness of glycaemic control and in stimulating selfmanagement in diabetic patients by motivating patients towards correct medication use, better medication adherence, healthy lifestyle and smoking cessation.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
PHARMACY WORLD & SCIENCE
Pharm. World Sci.
volume
30
issue
1
pages
51-56 pages
publisher
Springer
Web of Science type
Article
Web of Science id
000251147100009
JCR category
PHARMACOLOGY & PHARMACY
JCR impact factor
1.016 (2008)
JCR rank
179/216 (2008)
JCR quartile
4 (2008)
ISSN
0928-1231
DOI
10.1007/s11096-007-9140-0
language
English
UGent publication?
yes
classification
A1
id
384636
handle
http://hdl.handle.net/1854/LU-384636
date created
2008-01-16 16:05:00
date last changed
2015-06-17 10:46:36
@article{384636,
  abstract     = {Objective The aim of this study was (International Diabetes Federation. Diabetes Atlas Second Edition Executive Summary. Brussels: International Diabetes Federation; 2003) to describe the current status of medication use and disease management of type-2 diabetic patients in Flanders (Belgium). Each patient completed a questionnaire collecting personal data, information on duration of diabetes, medication, diabetes symptoms and self-management. At inclusion, patients measured their fasting plasma glucose (FPG) on three consecutive days. Prescription drugs (antidiabetic and other) purchased by each patient during the 12 months prior to inclusion in the study were reviewed from anonymized computerized pharmacy records. Main outcome measures Degree of self-management, glycaemic control and medication use. Results The mean FPG of the sample was 150.7 +/- 43.0 mg/dl. Controlled glycaemia (FPG between 90 and 130 mg/dl (5.0-7.2 mmol/l)) was achieved in only 34.9\% of the patients. Mainstay of hypoglycemic treatment consisted of metformin monotherapy (29.6\%) and metformin combined with sulfonylurea (29.0\%). Regarding co-medication, 76.9\% of the patients used antihypertensive drugs whereas only 33.1\% and 39.9\% were on aspirin and statin therapy, respectively. ADA recommendations for annual eye and foot examination were not followed in 38.8\% (eye) and 39.2\% (feet) of the patients. Conclusion The current management of type-2 diabetic Flemish patients falls short of recommended treatment goals. Community pharmacists may play a role in enhancing the awareness of glycaemic control and in stimulating selfmanagement in diabetic patients by motivating patients towards correct medication use, better medication adherence, healthy lifestyle and smoking cessation.},
  author       = {Mehuys, Els and De Bolle, Leen and Van Bortel, Lucas and Annemans, Lieven and Van Tongelen, Inge and Remon, Jean Paul and Giri, Mimi},
  issn         = {0928-1231},
  journal      = {PHARMACY WORLD \& SCIENCE},
  language     = {eng},
  number       = {1},
  pages        = {51--56},
  publisher    = {Springer},
  title        = {Medication use and disease management of type 2 diabetes patients in Belgium},
  url          = {http://dx.doi.org/10.1007/s11096-007-9140-0},
  volume       = {30},
  year         = {2008},
}

Chicago
Mehuys, Els, Leen De Bolle, Lucas Van Bortel, Lieven Annemans, Inge Van Tongelen, Jean Paul Remon, and Mimi Giri. 2008. “Medication Use and Disease Management of Type 2 Diabetes Patients in Belgium.” Pharmacy World & Science 30 (1): 51–56.
APA
Mehuys, Els, De Bolle, L., Van Bortel, L., Annemans, L., Van Tongelen, I., Remon, J. P., & Giri, M. (2008). Medication use and disease management of type 2 diabetes patients in Belgium. PHARMACY WORLD & SCIENCE, 30(1), 51–56.
Vancouver
1.
Mehuys E, De Bolle L, Van Bortel L, Annemans L, Van Tongelen I, Remon JP, et al. Medication use and disease management of type 2 diabetes patients in Belgium. PHARMACY WORLD & SCIENCE. Springer; 2008;30(1):51–6.
MLA
Mehuys, Els, Leen De Bolle, Lucas Van Bortel, et al. “Medication Use and Disease Management of Type 2 Diabetes Patients in Belgium.” PHARMACY WORLD & SCIENCE 30.1 (2008): 51–56. Print.